Non-small cell lung cancer recurrent
Clinical trials for Non-small cell lung cancer recurrent explained in plain language.
Never miss a new study
Get alerted when new Non-small cell lung cancer recurrent trials appear
Sign up with your email to follow new studies for Non-small cell lung cancer recurrent, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy aims to slow advanced lung cancer
Disease control Recruiting nowThis study tests a new combination of three drugs (nivolumab, ipilimumab, and nogapendekin alfa inbakicept) for people with stage IV or recurrent non-small cell lung cancer. The goal is to see if this treatment helps keep the cancer from growing longer than standard two-drug ther…
Matched conditions: NON-SMALL CELL LUNG CANCER RECURRENT
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Cancer-Fighting virus plus chemo and immunotherapy takes on lung cancer in new trial
Disease control Recruiting nowThis study tests a new approach for people with advanced lung cancer whose disease got worse after initial treatment. It combines an injected virus (Olvi-Vec) that targets cancer cells, followed by chemotherapy and an immunotherapy drug, and compares it to standard chemotherapy a…
Matched conditions: NON-SMALL CELL LUNG CANCER RECURRENT
Phase 2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC